Last week, a Nepali doctor filed a class action lawsuit against the National Board of Medical Examiners, alleging discrimination based upon national origin and requesting that invalidated USMLE scores be restored while examinees appeal.
The court will issue a ruling by February 21 - so the outcome of the suit remains uncertain.
Still, the NBME’s filing provides additional details on the scope of the scandal, how the cheaters were caught, and what’s likely to happen in the future.
First, the NBME confirmed the number of examinees involved.
According to their filing, 832 examinees have had at least one of their USMLE scores invalidated… so far.
Second, the NBME confirmed that they found the cheaters not through any kind of routine monitoring for suspicious patterns, but only after receiving tips about cheating.
How did the cheating ring work?
Students who could show “a nexus to Nepal and a USMLE testing permit” were admitted to a Telegram group called “Arahmba.”
So once they became aware of it, “an individual acting on behalf of the USMLE” infiltrated the group.
The NBME also clarifies how they established that individual examinees cheated.
They used agreement analysis, examining the specific pattern of right - and wrong - answers chosen by examinees.
(If you watched my videos in the immediate aftermath of the scandal, I predicted this - start listening around 7:50 or so.)
MORE Emergency Mailbag: The USMLE Cheating Scandal, Part II
They also identified cheaters by their very unusual response times and accuracy.
For instance, although USMLE questions typically require ~90 seconds to answer, the plaintiff answered many USMLE Step 1 questions in <20 seconds - and did so with 100% accuracy.
The NBME provided some screenshots from the Telegram group’s ringleaders admonishing users not to attract attention by finishing the USMLE too early.
(Here, “PQ” = previous questions.)
The NBME also provided some explanation for why they singled out Nepal for their initial investigation.
Last year, examinees from Nepali medical schools scored significantly higher than those from ANY other country - including the United States.
The NBME also pointed out how, even as the average examinee from Nepal was scoring 259 on Step 2 CK, the number of USMLE test-takers from Nepal was increasing almost exponentially.
Previously, I compared this dramatic change and ridiculously high performance to the steroid era in baseball. (Start around 16:50 if you’re in the mood for an extended analogy.)
MORE Emergency Mailbag: The USMLE Cheating Scandal, Part II
The plaintiff’s attorneys have nonetheless seized on the NBME’s focus on Nepal as impermissible under the Civil Rights Act, comparing it to racist policies like “stop and frisk.”
However, the most intriguing acknowledgement is that the USMLE isn’t only investigating Nepal.
In fact, using agreement analysis, they’ve **already found evidence of cheating** in examinees who took the USMLE in Jordan, Pakistan, and India.
Look for the other shoe to drop soon.
However, the USMLE’s process isn’t especially rapid.
The first tips mentioned in the lawsuit were received in January 2023 - so it took over a year for them to invalidate anyone’s scores.
The court should announce its decision in the next couple of days, and when it does, I’ll add another update.
Stay tuned.
/end
• • •
Missing some Tweet in this thread? You can try to
force a refresh
This week, a Nepali doctor and Match applicant whose Step 1, Step 2 CK, and Step 3 scores were all invalidated has sued the NBME.
The NBME will respond by February 19, and the court will render a decision by February 21.
(🧵)
The suit alleges that the NBME did not follow its own policies by invalidating scores before the involved examinees had an opportunity to appeal.
The suit also alleges violations of the Civil Rights Act due to discrimination based on national origin and ethnicity, based on the USMLE’s initial statement that the scandal was “associated with Nepal.”
Big changes may be coming for internal medicine residency applicants in the 2024-2025 application cycle…
The @AAIMOnline is recommending:
-⬆️ preference signals from 7 to 15 (3 gold, 12 silver)
-capping interviews at 15
-no interviews before November 1
Increasing the number of signals will likely function as a soft application cap, as we’ve seen in other specialties.
Many IM programs will still evaluate/interview applicants who don’t signal - but many others will receive so many signaled applications that they’ll stop there.
This will shift the dominant application strategy from “Apply to as many programs as possible” to “How do I most effectively allocate my preference signals?”
Applicants who signal wisely will benefit… those who don’t will suffer.
If you want to become a pediatric subspecialist, you’ve gotta do a fellowship.
For most subspecialties, that fellowship lasts 3 years.
But most of that time isn’t spent learning clinical medicine. It’s spent doing research.
Ever wondered why these fellowships last so long?
🧵
The short answer is, “because the American Board of Pediatrics requires it.”
But why?
For instance, in many specialties, a resident can choose between a 2-year clinical or a 3-year academic fellowship. The ABIM accepts either… but the ABP only accepts the latter.
To find the answer, we’ve gotta go back to the early 1980s.
At that point, peds heme-onc was a 2-year fellowship. But PDs felt trainees needed more training time to attain clinical proficiency.
So they asked the ABP if they could increase ⬆️ their fellowship from 2 to 3 years.
For weeks, I’ve waited patiently for preliminary application data for the 2023-2024 residency application to be released by the AAMC.
And today they dropped.
So you know what that means.
Yup, that’s right.
It’s time to break it down, Winners & Losers style™️.
(🧵)
LOSER: Application Fever.
For years, the biggest theme in the ERAS opening data is some variation of “What incredibly large number of applications are being submitted now?”
Applicants are still submitting lots of applications… but many specialties are DOWN from last year.
When you look at the overall application numbers, you’ve got to remember that these figures consider all comers (MD, DO, IMG). But there are important differences between these groups.
Andrew Taylor Still was the father of osteopathic medicine, and the A.T. Still School of Osteopathic Medicine in Arizona has been a leader in DO education.
ATSU-SOMA just announced a major change in their curriculum… one that has big implications for schools elsewhere.
(🧵)
Quick background:
ATSU used to have a ‘3+1’ curriculum, where second-year students were assigned to local community health centers to continue their classroom education and begin getting clinical experience.
The community health centers were spread all around the country - here’s the list from Wikipedia.
This was a big help in recruiting. Many pre-meds chose ATSU-SOMA because of the ability to spend a significant portion of their medical education at a CHC close to home.